Sex-regulated gene dosage effect of PPARα on synaptic plasticity

Differences in PPARα expression between males and females affect the regulation of GluA1 expression and synaptic plasticity in mice. Mechanisms driving cognitive improvements following nuclear receptor activation are poorly understood. The peroxisome proliferator–activated nuclear receptor alpha (PPARα) forms heterodimers with the nuclear retinoid X receptor (RXR). We report that PPARα mediates the improvement of hippocampal synaptic plasticity upon RXR activation in a transgenic mouse model with cognitive deficits. This improvement results from an increase in GluA1 subunit expression of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor, eliciting an AMPA response at the excitatory synapses. Associated with a two times higher PPARα expression in males than in females, we show that male, but not female, PPARα null mutants display impaired hippocampal long-term potentiation. Moreover, PPARα knockdown in the hippocampus of cognition-impaired mice compromises the beneficial effects of RXR activation on synaptic plasticity only in males. Furthermore, selective PPARα activation with pemafibrate improves synaptic plasticity in male cognition-impaired mice, but not in females. We conclude that striking sex differences in hippocampal synaptic plasticity are observed in mice, related to differences in PPARα expression levels.

[1]  for the Alzheimer’s Disease Neuroimaging Initiative,et al.  Sex differences in Alzheimer disease — the gateway to precision medicine , 2018, Nature Reviews Neurology.

[2]  H. Chung,et al.  Impairment of PPARα and the Fatty Acid Oxidation Pathway Aggravates Renal Fibrosis during Aging. , 2018, Journal of the American Society of Nephrology : JASN.

[3]  S. Yamashita,et al.  Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial , 2018, Diabetes Care.

[4]  B. Zlokovic,et al.  Alzheimer’s disease: A matter of blood–brain barrier dysfunction? , 2017, The Journal of experimental medicine.

[5]  N. Inestrosa,et al.  PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation , 2017, Biological reviews of the Cambridge Philosophical Society.

[6]  S. Yamashita,et al.  Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial. , 2017, Journal of clinical lipidology.

[7]  S. Moreno,et al.  Targeting PPARalpha in Alzheimer's Disease. , 2017, Current Alzheimer research.

[8]  I. Dewachter,et al.  Cortical cells reveal APP as a new player in the regulation of GABAergic neurotransmission , 2017, Scientific Reports.

[9]  G. Landreth,et al.  Therapeutic potential of nuclear receptor agonists in Alzheimer’s disease , 2017, Journal of Lipid Research.

[10]  G. Landreth,et al.  Neuronally-directed effects of RXR activation in a mouse model of Alzheimer’s disease , 2017, Scientific Reports.

[11]  Laura B. Ferguson,et al.  Localization of PPAR isotypes in the adult mouse and human brain , 2016, Scientific Reports.

[12]  B. Staels,et al.  The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis. , 2016, Atherosclerosis.

[13]  H. Offner,et al.  Sex differences and the role of PPAR alpha in experimental stroke , 2016, Metabolic Brain Disease.

[14]  J. Schug,et al.  RXR controlled regulatory networks identified in mouse brain counteract deleterious effects of Aβ oligomers , 2016, Scientific Reports.

[15]  R. Lhommel,et al.  Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease. , 2015, Journal of Alzheimer's disease : JAD.

[16]  Danko D. Georgiev,et al.  Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity , 2015, The Journal of Neuroscience.

[17]  T. Kodama,et al.  Transcriptome Analysis of K-877 (a Novel Selective PPARα Modulator (SPPARMα))-Regulated Genes in Primary Human Hepatocytes and the Mouse Liver. , 2015, Journal of atherosclerosis and thrombosis.

[18]  L. Garcia-Segura,et al.  Signaling mechanisms mediating the regulation of synaptic plasticity and memory by estradiol , 2015, Hormones and Behavior.

[19]  F. Gonzalez,et al.  Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP , 2015, Proceedings of the National Academy of Sciences.

[20]  R. Citraro,et al.  Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice , 2015, Molecular metabolism.

[21]  R. Evans,et al.  Nuclear Receptors, RXR, and the Big Bang , 2014, Cell.

[22]  J. Kordower,et al.  Regulation of cyclic AMP response element binding and hippocampal plasticity-related genes by peroxisome proliferator-activated receptor α. , 2013, Cell reports.

[23]  L. Ris,et al.  Improved preparation and preservation of hippocampal mouse slices for a very stable and reproducible recording of long-term potentiation. , 2013, Journal of visualized experiments : JoVE.

[24]  M. D’Amelio,et al.  CREB is necessary for synaptic maintenance and learning‐induced changes of the ampa receptor GluA1 subunit , 2013, Hippocampus.

[25]  Jean-Baptiste Demoulin,et al.  Amyloid precursor protein controls cholesterol turnover needed for neuronal activity , 2013, EMBO molecular medicine.

[26]  M. W. Wooten,et al.  Isolation and culture of hippocampal neurons from prenatal mice. , 2012, Journal of visualized experiments : JoVE.

[27]  M. Hofker,et al.  Peroxisome Proliferator–Activated Receptor-&agr; Gene Level Differently Affects Lipid Metabolism and Inflammation in Apolipoprotein E2 Knock-In Mice , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[28]  Philippe Lefebvre,et al.  Retinoid X receptors: common heterodimerization partners with distinct functions , 2010, Trends in Endocrinology & Metabolism.

[29]  S. Ingrand,et al.  Gender-dependent accumulation of ceramides in the cerebral cortex of the APPSL/PS1Ki mouse model of Alzheimer’s disease , 2010, Neurobiology of Aging.

[30]  K. J. Murphy,et al.  Discrimination of cell types in mixed cortical culture using calcium imaging: A comparison to immunocytochemical labeling , 2008, Journal of Neuroscience Methods.

[31]  Peter Tontonoz,et al.  Integration of metabolism and inflammation by lipid-activated nuclear receptors , 2008, Nature.

[32]  B. Staels,et al.  Design and synthesis of highly potent and selective human peroxisome proliferator-activated receptor alpha agonists. , 2007, Bioorganic & medicinal chemistry letters.

[33]  Graham L. Collingridge,et al.  Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions , 2007, Journal of Neuroscience Methods.

[34]  T. Soderling,et al.  Regulatory mechanisms of AMPA receptors in synaptic plasticity , 2007, Nature Reviews Neuroscience.

[35]  M. Ohno,et al.  Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.

[36]  R. Evans,et al.  Anatomical Profiling of Nuclear Receptor Expression Reveals a Hierarchical Transcriptional Network , 2006, Cell.

[37]  R. W. Draft,et al.  Restoration of spatial working memory by genetic rescue of GluR-A–deficient mice , 2005, Nature Neuroscience.

[38]  M. Febbraio,et al.  Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes. , 2004, Journal of molecular endocrinology.

[39]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[40]  P. Edwards,et al.  Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J Auwerx,et al.  Mechanism of action of fibrates on lipid and lipoprotein metabolism. , 1998, Circulation.

[42]  R. Heyman,et al.  Transactivation by Retinoid X Receptor–Peroxisome Proliferator-Activated Receptor γ (PPARγ) Heterodimers: Intermolecular Synergy Requires Only the PPARγ Hormone-Dependent Activation Function , 1998, Molecular and Cellular Biology.

[43]  M. Kennedy,et al.  A Synaptic Ras-GTPase Activating Protein (p135 SynGAP) Inhibited by CaM Kinase II , 1998, Neuron.

[44]  M. Leid,et al.  p300 Functions as a Coactivator for the Peroxisome Proliferator-activated Receptor α* , 1997, The Journal of Biological Chemistry.

[45]  T. Pineau,et al.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators , 1995, Molecular and cellular biology.

[46]  J. Tata Autoregulation and crossregulation of nuclear receptor genes , 1994, Trends in Endocrinology & Metabolism.

[47]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[48]  A. Riecher-Rössler Sex and gender differences in mental disorders. , 2017, The lancet. Psychiatry.

[49]  B. Staels,et al.  PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD , 2017, Nature Reviews Endocrinology.

[50]  William Bourguet,et al.  Modulation of RXR function through ligand design. , 2012, Biochimica et biophysica acta.

[51]  M. Febbraio,et al.  Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes. , 2004, Journal of molecular endocrinology.

[52]  W. Wahli,et al.  Sex difference in hepatic peroxisome proliferator-activated receptor alpha expression: influence of pituitary and gonadal hormones. , 2003, Endocrinology.

[53]  R. Heyman,et al.  Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: intermolecular synergy requires only the PPARgamma hormone-dependent activation function. , 1998, Molecular and cellular biology.